BRIEF published on 06/04/2024 at 13:05, 3 months 15 days ago Theralase® Technology Effective in Virus Inactivation Theralase Ruvidar Antiviral Research Virus Inactivation Heliyon
PRESS RELEASE published on 06/04/2024 at 13:00, 3 months 15 days ago Theralase(R) Technology Effective in Virus Inactivation Theralase Technologies Inc. announces successful inactivation of various viruses with lead compound RuvidarTM through peer-reviewed research. Potential for viral vaccine development highlighted Theralase Technologies Inc. RuvidarTM Peer-Reviewed Research Viral Inactivation Viral Vaccine Development
BRIEF published on 05/30/2024 at 13:05, 3 months 20 days ago Theralase publie ses états financiers du 1T2024 Résultats Financiers Traitement Du Cancer Theralase Étude II PDC
BRIEF published on 05/30/2024 at 13:05, 3 months 20 days ago Theralase Releases 1Q2024 Financial Statements Financial Results Cancer Treatment Theralase Study II PDCs
PRESS RELEASE published on 05/30/2024 at 13:00, 3 months 20 days ago Theralase(R) Release's 1Q2024 Financial Statements Theralase® releases unaudited interim consolidated 1Q2024 financial statements. Company to host conference call on June 6th, 2024. Study II update and Break Through Designation progress discussed Conference Call Financial Statements Break Through Designation Theralase Study II
BRIEF published on 04/24/2024 at 13:05, 4 months 25 days ago Theralase Technologies Inc. finalise une ronde de financement de 750 200 $ Investissement Placement Privé Médicaments Recherche Clinique Technologies Théralase
BRIEF published on 04/24/2024 at 13:05, 4 months 25 days ago Theralase Technologies Inc. Completes $750,200 Funding Round Private Placement Pharmaceuticals Clinical Research Investment Theralase Technologies
PRESS RELEASE published on 04/24/2024 at 13:00, 4 months 25 days ago Theralase(R) Closes $CAN 750,000 Non-Brokered Private Placement Theralase Technologies Inc. successfully closes Non-Brokered Private Placement offering, raising $CAN 750,200 for research and development of cancer treatments Private Placement Theralase Technologies Inc. Research And Development Stock Offering Cancer Treatments
BRIEF published on 04/05/2024 at 13:05, 5 months 14 days ago Theralase Technologies Inc. Receives Canadian Patent for Cancer Vaccine Theralase Technologies Inc. Cancer Vaccine Photo Dynamic Compounds Liquid Cancers Clinical Studies
BRIEF published on 04/05/2024 at 13:05, 5 months 14 days ago Theralase Technologies Inc. reçoit un brevet canadien pour un vaccin contre le cancer Theralase Technologies Inc. Vaccin Contre Le Cancer Études Cliniques Composés Photodynamiques Cancers Liquides
Published on 09/20/2024 at 02:00, 2 hours 48 minutes ago Academy of Math and Science Celebrates Hispanic Heritage Month
Published on 09/19/2024 at 23:15, 5 hours 33 minutes ago Cypher Metaverse Inc. Announces Second Closing of Financing
Published on 09/19/2024 at 23:00, 5 hours 48 minutes ago WestJet Partners with FLYHT and NOAA to Improve Weather Forecasting in North America
Published on 09/19/2024 at 23:00, 5 hours 48 minutes ago Cerrado Files NI 43-101 Preliminary Economic Assessment Technical Report and Mineral Resource Estimate for The Minera Don Nicolas Mine in Santa Cruz, Argentina
Published on 09/19/2024 at 21:09, 7 hours 38 minutes ago EQS-Adhoc: Mercedes-Benz Group AG adjusts full-year guidance for the year 2024 based on current market outlook
Published on 09/19/2024 at 18:44, 10 hours 4 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 09/19/2024 at 18:03, 10 hours 45 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 09/19/2024 at 17:52, 10 hours 55 minutes ago PILOT 28 : FIGEAC AÉRO remporte 3 nouveaux contrats sur l'A320 pour 65 millions d'euros
Published on 09/19/2024 at 17:52, 10 hours 55 minutes ago PILOT 28: FIGEAC AÉRO secures 3 new wins on the A320 airframe for 65 million euros
Published on 09/19/2024 at 17:45, 11 hours 3 minutes ago Gimv draagt helft van participatie in Infravest over aan WorxInvest (communicatie in toepassing van artikel 7:97 WVV)
Published on 09/19/2024 at 17:45, 11 hours 3 minutes ago Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Published on 09/19/2024 at 17:45, 11 hours 3 minutes ago Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)